Addressing the analytical gaps in modern therapeutic development

As biopharmaceuticals evolve toward complex modalities like gene therapies and immune-modulating biologics, traditional analytical methods often fall short. Cell-based assays are rising as essential tools but developing robust, context-specific solutions remains challenging.

Discover how tailored cell-based assay strategies can overcome these hurdles and support regulatory-ready data generation. Explore the key challenges and find practical guidance to help advance your analytical capabilities for next-generation therapeutic development.